Imanova has its eye on taking imaging beyond the brain
The London-based translational research company is pioneering the development of innovative imaging biomarkers to enhance efficiency and reduce risk in the development of drugs for therapeutic areas such as inflammation and respiratory disease. To download the full article, please sign in.